Nuveen Asset Management, LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 123 filers reported holding INTERSECT ENT INC in Q4 2021. The put-call ratio across all filers is 6.85 and the average weighting 0.3%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$9,778,000
-0.1%
352,370
-1.7%
0.00%0.0%
Q4 2021$9,787,000
-2.6%
358,364
-3.0%
0.00%0.0%
Q3 2021$10,049,000
-5.9%
369,442
-40.9%
0.00%0.0%
Q2 2021$10,679,000
-22.7%
624,875
-5.6%
0.00%
-25.0%
Q1 2021$13,822,000
-12.7%
661,952
-4.3%
0.00%
-20.0%
Q4 2020$15,840,000
+61.2%
691,703
+14.8%
0.01%
+25.0%
Q3 2020$9,828,000
+26.9%
602,574
+5.3%
0.00%
+33.3%
Q2 2020$7,745,000
+11.9%
572,062
-2.1%
0.00%0.0%
Q1 2020$6,924,000
-57.8%
584,351
-11.4%
0.00%
-50.0%
Q4 2019$16,414,000
+67.0%
659,210
+14.1%
0.01%
+50.0%
Q3 2019$9,829,000
-23.1%
577,829
+2.9%
0.00%
-20.0%
Q2 2019$12,782,000
+403.6%
561,617
+728.7%
0.01%
-68.8%
Q2 2018$2,538,000
+79.9%
67,770
+88.8%
0.02%
+77.8%
Q1 2018$1,411,000
+42.0%
35,893
+17.0%
0.01%
+50.0%
Q4 2017$994,00030,6900.01%
Other shareholders
INTERSECT ENT INC shareholders Q4 2021
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders